Cargando…
The additive effect of vitamin K supplementation and bisphosphonate on fracture risk in post-menopausal osteoporosis: a randomised placebo controlled trial
SUMMARY: This study assessed whether vitamin K, given with oral bisphosphonate, calcium and/or vitamin D has an additive effect on fracture risk in post-menopausal women with osteoporosis. No difference in bone density or bone turnover was observed although vitamin K(1) supplementation led to a mode...
Autores principales: | Moore, Amelia E., Dulnoan, Dwight, Voong, Kieran, Ayis, Salma, Mangelis, Anastasios, Gorska, Renata, Harrington, Dominic J., Tang, Jonathan C. Y., Fraser, William D., Hampson, Geeta |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer London
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10282078/ https://www.ncbi.nlm.nih.gov/pubmed/37338608 http://dx.doi.org/10.1007/s11657-023-01288-w |
Ejemplares similares
-
The impact of vitamin D status on changes in bone mineral density during treatment with bisphosphonates and after discontinuation following long-term use in post-menopausal osteoporosis
por: Deane, Andrew, et al.
Publicado: (2007) -
Review on the comparison of effectiveness between denosumab and bisphosphonates in post-menopausal osteoporosis
por: Benjamin, Biju, et al.
Publicado: (2016) -
Clinical role of bisphosphonate therapy
por: Hampson, Geeta, et al.
Publicado: (2012) -
Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
por: Cotté, François-Emery, et al.
Publicado: (2011) -
Bone Mineral Density and Body Composition are Associated with Circulating Angiogenic Factors in Post-menopausal Women
por: Spangenberg, A., et al.
Publicado: (2016)